Nivolumab Maintained QOL in Advanced Squamous Cell Head and Neck Cancer

Patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with the checkpoint inhibitor nivolumab were able to maintain baseline levels of quality of life. (Source: CancerNetwork)

from MedWorm via o.lakala70 on Inoreader http://ift.tt/2trnS6G
via IFTTT